bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Implementation of advanced tools such as real-time biosensing, closed-loop control, and artificial intelligence-driven decision support systems may help address antimicrobial resistance.
Today, blood cultures are a commonplace, highly advanced, and often automated function in microbiology laboratories, but this was not always the case.
Since 2017, the FDA has quickly adjusted processes, expanded capabilities, and created new guidelines specifically for ATMPs to keep up with the pace of the industry and discover and penalize developers who do not abide by regulations.
Three ATMP experts recently discussed how the COVID-19 pandemic has impacted pharmaceutical quality control processes and the main takeaways for new ATMP developers.
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
WASH, which stands for water, sanitation, and hygiene, are basic...